Unknown

Dataset Information

0

DNA damaging agents in ovarian cancer.


ABSTRACT: Epithelial ovarian cancer (EOC) is very sensitive to upfront chemotherapy. This condition is attributable to defects in the DNA damage repair system. Agents that damage DNA are the main drugs used for its treatment. Many EOC cells have DNA repair deficiencies that confer susceptibility to these agents. Platinum is the most important agent for first-line and also for relapses, together with other drugs that can be given as monotherapy or along with platinum or other drugs. Lately, the emerging role of PARP inhibitors has changed the landscape of opportunities for patients with EOC. All these strategies will be reviewed in this article.

SUBMITTER: Barretina-Ginesta MP 

PROVIDER: S-EPMC7573464 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

DNA damaging agents in ovarian cancer.

Barretina-Ginesta Maria-Pilar MP  

EJC supplements : EJC : official journal of EORTC, European Organization for Research and Treatment of Cancer ... [et al.] 20200822


Epithelial ovarian cancer (EOC) is very sensitive to upfront chemotherapy. This condition is attributable to defects in the DNA damage repair system. Agents that damage DNA are the main drugs used for its treatment. Many EOC cells have DNA repair deficiencies that confer susceptibility to these agents. Platinum is the most important agent for first-line and also for relapses, together with other drugs that can be given as monotherapy or along with platinum or other drugs. Lately, the emerging ro  ...[more]

Similar Datasets

| S-EPMC9139752 | biostudies-literature
| S-EPMC5432342 | biostudies-literature
| S-EPMC5837749 | biostudies-literature
2020-08-21 | GSE156543 | GEO
| S-EPMC9817522 | biostudies-literature
| 2114543 | ecrin-mdr-crc
| S-EPMC3443151 | biostudies-literature
| S-EPMC4573818 | biostudies-literature
| S-EPMC5710876 | biostudies-literature
2008-09-23 | GSE10313 | GEO